100 Recruiting Studies Using Cisplatin
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Cisplatin
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
📍 University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona
Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7
View Study & Checklist ➔Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
📍 M D Anderson Cancer Center — Houston, Texas
Squamous Cell Carcinoma
View Study & Checklist ➔A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
📍 Loma Linda Univ Faculty Medic — Loma Linda, California
Urinary Bladder Neoplasms
View Study & Checklist ➔Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
📍 City of Hope Corona — Corona, California
FIGO Stage IVA Ovarian Cancer
View Study & Checklist ➔Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Stage IB Lung Non-Small Cell Carcinoma AJCC v7
View Study & Checklist ➔Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Head and Neck Carcinoma
View Study & Checklist ➔Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Limited Stage Lung Small Cell Carcinoma
View Study & Checklist ➔De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
📍 Nebraska Methodist Hospital — Omaha, Nebraska
HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage
View Study & Checklist ➔Pembrolizumab Plus Olaparib in LA-HNSCC
📍 Indiana University Simon Comprehensive Cancer Center — Indianapolis, Indiana
Squamous Cell Carcinoma of Head and Neck
View Study & Checklist ➔Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
📍 Research Site — Orlando, Florida
Carcinoma
View Study & Checklist ➔Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
📍 Research Site — Baltimore, Maryland
Gastric Cancer
View Study & Checklist ➔A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
📍 Local Institution - 0022 — Tucson, Arizona
Urinary Bladder Neoplasms
View Study & Checklist ➔Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer
📍 Tower Hematology-Oncology — Beverly Hills, California
HPV Positive Oropharyngeal Squamous Cell Carcinoma
View Study & Checklist ➔A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial
📍 M D Anderson Cancer Center — Houston, Texas
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
View Study & Checklist ➔Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
📍 City of Hope — Duarte, California
Ovarian Cancer
View Study & Checklist ➔Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
📍 Moffitt Cancer Center-International Plaza — Tampa, Florida
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
📍 GSK Investigational Site — Goodyear, Arizona
Neoplasms
View Study & Checklist ➔A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
Solid Tumor
View Study & Checklist ➔De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
📍 BCCA - Centre for the North — Prince George, British Columbia
Oropharyngeal Cancer
View Study & Checklist ➔Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
📍 Research Site — Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
📍 Columbia University Medical Center — New York, New York
Adrenocortical Carcinoma
View Study & Checklist ➔A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
📍 Research Site — Iowa City, Iowa
Metastatic Non-Small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Multiple Myeloma
View Study & Checklist ➔Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
📍 University of Louisville - James Graham Brown Cancer Center — Louisville, Kentucky
Head and Neck Cancer
View Study & Checklist ➔Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Lymphoma
View Study & Checklist ➔MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
📍 Research Site — Santa Rosa, California
Unresectable Pleural Mesothelioma
View Study & Checklist ➔Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
📍 Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Chandler, Arizona
Relapsed/Refractory Diffuse Large B-cell Lymphoma
View Study & Checklist ➔Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
📍 Innovative Clinical Research Institute — Whittier, California
Non-small Cell Lung Cancer
View Study & Checklist ➔Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
Recurrent Head and Neck Carcinoma
View Study & Checklist ➔Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Pancreatic Cancer, Advanced or Metastatic
View Study & Checklist ➔A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
📍 Clermont Oncology Center — Clermont, Florida
Resectable Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
📍 Local Institution - 0104 — Tampa, Florida
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
📍 Kingman Regional Medical Center — Kingman, Arizona
Gastric Neuroendocrine Carcinoma
View Study & Checklist ➔GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska
Malignant Solid Tumor
View Study & Checklist ➔Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
📍 Board of Trustees of the Leland Stanford Junior University — Redwood City, California
Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
View Study & Checklist ➔TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
📍 City of Hope National Medical Center — Long Beach, California
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
📍 University of Miami — Miami, Florida
Neuroendocrine Neoplasms
View Study & Checklist ➔Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Resectable Lung Non-Small Cell Carcinoma
View Study & Checklist ➔HOT: HIPEC in Ovarian Cancer as Initial Treatment
📍 Mercy Medical Center — Baltimore, Maryland
Stage III Ovarian Cancer
View Study & Checklist ➔Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
📍 University of Alabama at Birmingham — Birmingham, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
📍 Research Site — La Jolla, California
Lung Cancer
View Study & Checklist ➔Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer
📍 Research Site — Birmingham, Alabama
Unresectable Locally Advanced Urothelial Cancer
View Study & Checklist ➔Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy
📍 Memorial Sloan Kettering at Basking Ridge — Basking Ridge, New Jersey
Locally Recurrent/Metastatic Triple Negative Breast Cancer
View Study & Checklist ➔Study of AZD2811 + Durvalumab in ES-SCLC
📍 Research Site — Grand Rapids, Michigan
Small-Cell Lung Cancer
View Study & Checklist ➔A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
Bladder Cancer
View Study & Checklist ➔Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Vaginal Adenocarcinoma
View Study & Checklist ➔A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Bladder Urothelial Carcinoma
View Study & Checklist ➔Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Myeloma
View Study & Checklist ➔Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
📍 Research Site — Phoenix, Arizona
NSCLC
View Study & Checklist ➔A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
📍 Indiana University — Bloomington, Indiana
Urothelial Carcinoma
View Study & Checklist ➔Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
📍 Thomas Hospital — Fairhope, Alabama
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
📍 HonorHealth-USOR HonorHealth ( Site 8000) — Phoenix, Arizona
Endometrial Neoplasms
View Study & Checklist ➔Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
📍 Infirmary Cancer Care ( Site 0022) — Mobile, Alabama
Small Cell Lung Carcinoma
View Study & Checklist ➔Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
📍 Clearview Cancer Institute — Huntsville, Alabama
Lung Cancer, Non-squamous, Non-small Cell
View Study & Checklist ➔Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
📍 Alaska Oncology and Hematology, LLC. — Anchorage, Alaska
Non-small Cell Lung Cancer
View Study & Checklist ➔De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Basaloid Squamous Cell Carcinoma
View Study & Checklist ➔Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
📍 University of Alabama - Birmingham ( Site 3061) — Birmingham, Alabama
Endometrial Neoplasms
View Study & Checklist ➔Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer
📍 Ironwood Cancer & Research Centers - Chandler — Chandler, Arizona
Urothelial Cancer
View Study & Checklist ➔Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)
📍 Research Site — Birmingham, Alabama
Small Cell Lung Carcinoma Extensive Disease
View Study & Checklist ➔Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Bladder Urothelial Carcinoma
View Study & Checklist ➔A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
📍 Rush University Medical Center — Chicago, Illinois
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
📍 Highlands Oncology Group - Rogers — Rogers, Arkansas
Epithelioid Mesothelioma
View Study & Checklist ➔Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)
📍 Mayo Clinic — Scottsdale, Arizona
Advanced or Metastatic NSCLC
View Study & Checklist ➔A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
📍 Sutter Auburn Faith Hospital — Auburn, California
Combined Hepatocellular Carcinoma and Cholangiocarcinoma
View Study & Checklist ➔Study of Novel Treatment Combinations in Patients With Lung Cancer
📍 Arizona Oncology Associates,Substudy-02 — Tucson, Arizona
Lung Cancer
View Study & Checklist ➔Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
📍 University of California Los Angeles UCLA - Cancer Care - Santa Monica — Santa Monica, California
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer
View Study & Checklist ➔Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer
📍 University of Vermont — Burlington, Vermont
Lung Cancer Metastatic
View Study & Checklist ➔Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
📍 Mayo Clinic of Scottsdale — Phoenix, Arizona
Cholangiocarcinoma
View Study & Checklist ➔Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California
Malignant Rhabdoid Tumor
View Study & Checklist ➔Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
📍 UCSD Medical Center - Encinitas — Encinitas, California
Colorectal Neoplasms
View Study & Checklist ➔Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
📍 University of Kansas Cancer Center - Clinical Research Center — Fairway, Kansas
Triple-Negative Breast Cancer
View Study & Checklist ➔A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS
📍 Research Site — Beverly Hills, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
📍 Hospital de Gastroenterología Dr Bonorino Udaondo — Buenos Aires,
Gastric Neoplasms
View Study & Checklist ➔Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
📍 Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill — Chapel Hill, North Carolina
Carcinoma, Squamous Cell
View Study & Checklist ➔RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Oral Mucositis
View Study & Checklist ➔Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer
📍 Magee-Womens Hospital of UPMC — Pittsburgh, Pennsylvania
Ovarian Cancer Recurrent
View Study & Checklist ➔Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
📍 University of Florida Health Science Center - Jacksonville — Jacksonville, Florida
Stage II Non-Small Cell Lung Cancer AJCC v7
View Study & Checklist ➔Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)
📍 Local Institution - 0032 — Anchorage, Alaska
Non-Small Cell Lung Cancer
View Study & Checklist ➔Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
📍 Providence Hospital — Mobile, Alabama
Neck Squamous Cell Carcinoma of Unknown Primary
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
📍 UC Davis — Sacramento, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
Infiltrating Bladder Urothelial Carcinoma
View Study & Checklist ➔A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Biliary Tract Carcinoma
View Study & Checklist ➔Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
📍 University of Arizona Cancer Center — Tucson, Arizona
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Head and Neck Cancer
View Study & Checklist ➔Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
📍 Research Site — Los Angeles, California
Urothelial Cancer
View Study & Checklist ➔A Study of LY3200882 in Participants With Solid Tumors
📍 University of Louisville — Louisville, Kentucky
Solid Tumor
View Study & Checklist ➔Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
📍 Research Site — Birmingham, Alabama
Hepatocellular Carcinoma
View Study & Checklist ➔Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC
📍 Cliniques Universitaires Saint-Luc — Brussels,
Oropharyngeal Squamous Cell Carcinoma
View Study & Checklist ➔Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer
📍 University of Illinois Medical Center — Chicago, Illinois
Extensive Stage Small Cell Lung Cancer
View Study & Checklist ➔A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
📍 The University of Arizona Cancer Center — Tucson, Arizona
Biliary Tract Cancer
View Study & Checklist ➔A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
📍 University of Chicago — Chicago, Illinois
Urothelial Carcinoma
View Study & Checklist ➔Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)
📍 Norton Cancer Institute - Audubon — Louisville, Kentucky
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
📍 St. Bernards Medical Center ( Site 0103) — Jonesboro, Arkansas
Non-Small Cell Lung Cancer
View Study & Checklist ➔Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors
📍 Banner MD Anderson Cancer Ctr /ID# 260129 — Gilbert, Arizona
Advanced Solid Tumors
View Study & Checklist ➔A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
📍 St. Joseph's Hospital and Medical Center-Dignity Health Cancer Institute ( Site 0023) — Phoenix, Arizona
Metastatic Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
📍 Research Site — Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔